Your browser doesn't support javascript.
loading
Early modifications of fatty acid composition in plasma phospholipids, platelets and mononucleates of healthy volunteers after low doses of n-3 polyunsaturated fatty acids.
Di Stasi, Delia; Bernasconi, Roberto; Marchioli, Roberto; Marfisi, Rosa Maria; Rossi, Giovanna; Tognoni, Gianni; Tacconi, Maria Teresa.
Afiliación
  • Di Stasi D; Department of Molecular Biochemistry and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri, Via Eritrea 62, 20157 Milan, Italy.
Eur J Clin Pharmacol ; 60(3): 183-90, 2004 May.
Article en En | MEDLINE | ID: mdl-15069592
ABSTRACT

OBJECTIVES:

Although previous data suggested that only doses of 4 g/day or higher of n-3 polyunsaturated fatty acids (PUFA) have had a beneficial effect in the prevention of atherosclerosis and cardiovascular diseases, the GISSI-Prevenzione Study in a 3-year trial showed that 1 g/day reduced total and cardiovascular mortality in over 11,000 post-infarction patients. The aim of this study was to investigate the time course and the extent of incorporation of n-3 fatty acids in plasma and blood cells after 1 g/day of n-3 PUFA, the dose effective in the GISSI-Prevenzione in comparison with higher doses.

METHODS:

Thirty-six healthy volunteers were given 1, 2 and 4 g/day of n-3 PUFA ethyl esters for 12 weeks, followed by a 4-week washout. Blood was collected at weeks 0, 1, 2, 4, 8, 12 and 16 and used for lipid profile analysis and measurement of fatty acid composition in plasma phospholipids, platelets and mononucleates.

RESULTS:

Total n-3 PUFA increased by 2.0-, 2.2- and 2.9-fold versus baseline after 12-week treatment with 1, 2 and 4 g respectively. A statistically significant raise of total n-3 PUFA was seen in platelets and mononucleates. Among individual n-3 PUFA, 225 n-3 was enriched early and dose dependently in plasma phospholipids, platelets and mononucleates; the raise of 226 n-3 was less marked especially in platelets and mononucleates.

CONCLUSIONS:

One gram per day of n-3 PUFA induces fast (within 1 week) and striking changes in blood composition of PUFA that may well explain their beneficial effects against cardiovascular diseases.
Asunto(s)
Buscar en Google
Base de datos: MEDLINE Asunto principal: Fosfolípidos / Plaquetas / Monocitos / Ácidos Grasos Omega-3 Tipo de estudio: Diagnostic_studies Idioma: En Revista: Eur J Clin Pharmacol Año: 2004 Tipo del documento: Article
Buscar en Google
Base de datos: MEDLINE Asunto principal: Fosfolípidos / Plaquetas / Monocitos / Ácidos Grasos Omega-3 Tipo de estudio: Diagnostic_studies Idioma: En Revista: Eur J Clin Pharmacol Año: 2004 Tipo del documento: Article